Characteristics | Number | Percentage |
---|---|---|
Gender | ||
Male | 56 | 69.1 |
Female | 25 | 30.9 |
Age at diagnosis | ||
< 30 y | 49 | 60.5 |
≥ 30 y | 32 | 39.5 |
Primary site | ||
Extremity | 25 | 30.9 |
Trunk | 56 | 69.1 |
Tumor origin | ||
Skeletal | 57 | 70.4 |
Extraskeletal | 24 | 29.6 |
Stage | ||
Localized | 48 | 59.3 |
Metastatic | 33 | 40.7 |
Diameter of primary tumor | ||
< 8 cm | 50 | 61.7 |
≥ 8 cm | 31 | 38.3 |
Local therapy | ||
Surgery | 35 | 43.2 |
Radiotherapy | 18 | 22.2 |
Surgery + radiotherapy | 28 | 34.6 |
Number of chemotherapy cycles | ||
< 12 | 40 | 49.4 |
≥ 12 | 41 | 50.6 |
Frequency of chemotherapy delays | ||
< 25% | 65 | 80.2 |
≥25% | 16 | 19.8 |
Administration of dexrazoxane | ||
YES | 39 | 48.1 |
NO | 42 | 51.9 |